Hexadecane

Hexadecane

SCHEMBL5510405

CCCCCCCCCCCCCCCC.Cl.Cl

nearest known ligand 0.89

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ABL1ACEACHEACVR1ADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3AGTR1ALKAVPR1AAVPR2BCHEBCRCA2CACNA1ACACNA1BCACNA1CCACNA1DCACNA1ECACNA1FCACNA1GCACNA1HCACNA1ICACNA1SCACNA2D1CACNA2D2CACNA2D3CACNA2D4CACNB1CACNB2CACNB3CACNB4CACNG1CACNG2CACNG3CACNG4CACNG5CACNG6CACNG7CACNG8CALCRLCASRCCR5CDK4CDK6CFBCHRM1CHRM2CHRM3CHRM4CHRM5CHRNA1CHRNA3CHRNA7CHRNB1CHRNB4CHRNDCHRNECHRNGCOXFA4COXFA4L2CRBNCSF1RCUL4ACYP19A1DDB1DPP4DRD1DRD2DRD3DRD4EDNRAEGFREML4ERBB2ERBB4ESR1ESR2FGFR1FGFR3FLT1FLT3FLT4GAAGABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGHSRGLAGNRHRGPD2GRIN1GRIN2AGRIN2BGRIN2CGRIN2DGRIN3AGRIN3BGSTP1HCN4HCRTR1HCRTR2HDAC1HDAC10HDAC11HDAC2HDAC3HDAC4HDAC5HDAC6HDAC7HDAC8HDAC9HRH1HRH2HRH3HSD11B1HSP90AA1HSP90AB1HTR1AHTR1BHTR1DHTR1EHTR1FHTR2AHTR2BHTR2CHTR3AHTR3BHTR3CHTR3DHTR3EHTR4HTR5AHTR6HTR7IMPDH1IMPDH2ITGA2BITGB3ITKJAK1JAK2KCNA1KCNA10KCNA2KCNA3KCNA4KCNA5KCNA6KCNA7KCNB1KCNB2KCNC1KCNC2KCNC3KCNC4KCND1KCND2KCND3KCNF1KCNG1KCNG2KCNG3KCNG4KCNH1KCNH2KCNH3KCNH4KCNH5KCNH6KCNH7KCNH8KCNJ2KCNJ3KCNJ5KCNK3KCNK9KCNQ1KCNQ2KCNQ3KCNQ4KCNQ5KCNS1KCNS2KCNS3KCNV1KCNV2KDRKITKLKB1LCKMMAOAMAOBMAPK14METMMP1MMP13MMP7MMP8MT-ND1MT-ND2MT-ND3MT-ND4MT-ND4LMT-ND5MT-ND6NDUFA1NDUFA10NDUFA11NDUFA12NDUFA13NDUFA2NDUFA3NDUFA5NDUFA6NDUFA7NDUFA8NDUFA9NDUFAB1NDUFAF1NDUFAF2NDUFAF3NDUFAF4NDUFB1NDUFB10NDUFB11NDUFB2NDUFB3NDUFB4NDUFB5NDUFB6NDUFB7NDUFB8NDUFB9NDUFC1NDUFC2NDUFS1NDUFS2NDUFS3NDUFS4NDUFS5NDUFS6NDUFS7NDUFS8NDUFV1NDUFV2NDUFV3NR3C1NS5ANTRK1NTRK2NTRK3ODC1OPRD1OPRK1OPRM1P2RY12PAHPARP1PDE3APDE3BPDE4APDE4BPDE4CPDE4DPDE5APDE7APDE7BPDE8APDE8BPDGFRAPDGFRBPIK3CAPIK3CDPNPPOLA1POLA2POLD1POLD2POLD3POLD4POLEPOLE2POLE3PPARGPRIM1PRIM2PRKCAPRKCBPRKCDPRKCEPRKCGPRKCHPRKCIPRKCQPRKCZPRKD1PRKD3PTGS1PTGS2RBX1RENRETROCK1ROCK2RPE65RRM1RRM2RRM2BS1PR1S1PR2S1PR3S1PR4S1PR5SCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASCNN1ASCNN1BSCNN1GSIGMAR1SLC18A2SLC6A1SLC6A2SLC6A3SLC6A4SLC9A3SRCTACR1TOP1TOP2ATOP2BTTRTYMPdacAdacBdacCembAfolAftsIgyrAgyrBmrcAmrcBmrdAparCparEpolrplArplBrplCrplDrplErplFrplIrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmE2rpmFrpmGrpmG1rpmG2rpmG3rpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO

The experimentally established mechanism targets of Hexadecane. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 9)

geneUniProtsupporting neighboursconfidence
TSHR P16473 5/20 0.89
THRB P10828 1/20 0.89
DNM1 Q05193 8/20 0.64
LMNA P02545 3/20 0.60
ALDH1A1 P00352 3/20 0.57
MEN1 O00255 2/20 0.57
KMT2A Q03164 2/20 0.57
HSD17B10 Q99714 1/20 0.57
SLC22A1 O15245 1/20 0.57

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Dodecane SCHEMBL3040512 1.00 TSHR (0.89) TSHRTHRBDNM1LMNAALDH1A1
Octane SCHEMBL8645563 1.00 TSHR (0.89) TSHRTHRBDNM1LMNAALDH1A1
Octane SCHEMBL9775406 1.00 TSHR (0.89) TSHRTHRBDNM1LMNAALDH1A1
Decane SCHEMBL10448068 1.00 TSHR (0.89) TSHRTHRBDNM1LMNAALDH1A1
Nonane SCHEMBL3814127 1.00 TSHR (0.89) TSHRTHRBDNM1LMNAALDH1A1
Decane SCHEMBL7183338 1.00 TSHR (0.89) TSHRTHRBDNM1LMNAALDH1A1
Octane SCHEMBL8167210 1.00 TSHR (0.89) TSHRTHRBDNM1LMNAALDH1A1
Heptane SCHEMBL694283 1.00
Nonane SCHEMBL2961102 1.00 TSHR (0.89) TSHRTHRBDNM1LMNAALDH1A1
Heptane SCHEMBL3638943 1.00

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-110975653-B Dinitrogen-containing spiro quaternary ammonium salt cross-linked anion exchange membrane material, and preparation method and application thereof 河北科技大学 2021-12-14 CN claimed
CN-110975653-A Dinitrogen-containing spiro quaternary ammonium salt cross-linked anion exchange membrane material, and preparation method and application thereof 河北科技大学 2020-04-10 CN claimed
EP-1751264-A1 BLEACHING COMPOSITION COMPRISING A CARBOHYDRATE OXIDASE The Procter and Gamble Company (US) 2007-02-14 EP claimed
WO-2005116180-A1 BLEACHING COMPOSITION COMPRISING A CARBOHYDRATE OXIDASE THE PROCTER & GAMBLE COMPANY (US) 2005-12-08 WO claimed
US-20050256016-A1 Bleaching composition comprising a carbohydrate oxidase THE PROCTER & GAMBLE COMPANY 2005-11-17 US claimed
WO-2026041790-A1 DI(DISPIRODIAZATRIPIPERAZINE)-TRIAZINE DERIVATIVES AND THEIR USE FOR TREATMENT OR PREVENTION OF VIRAL INFECTIONS Charité - Universitätsmedizin Berlin Körperschaft des öffentlichen Rechts (DE) 2026-02-26 WO disclosed
CN-118239859-A Hydrazide compound, rubber composition, and preparation methods and applications thereof 中策橡胶集团股份有限公司 2024-06-25 CN disclosed
WO-2022124944-A1 DI(DIAZONIADISPIRO[5.2.5.2]HEXADECAN)-5-NITROPYRIMIDINES FOR THE TREATMENT OF CORONAVIRAL INFECTIONS FEDERAL RESEARCH CENTRE “FUNDAMENTALS OF BIOTECHNOLOGY” OF THE RUSSIAN ACADEMY OF SCIENCES (RU) 2022-06-16 WO disclosed
CN-110975653-B Dinitrogen-containing spiro quaternary ammonium salt cross-linked anion exchange membrane material, and preparation method and application thereof 河北科技大学 2021-12-14 CN disclosed
CN-110975653-A Dinitrogen-containing spiro quaternary ammonium salt cross-linked anion exchange membrane material, and preparation method and application thereof 河北科技大学 2020-04-10 CN disclosed
CN-107533080-A Ink jet deposition of reagents for histological samples 文塔纳医疗系统公司 2018-01-02 CN disclosed
WO-2015167368-A1 4, 6-DI (3,12-DIAZA-6, 9-DIAZONIADISPIRO [5.2.5.2] HEXANDECAN-1-YL) -2-METHYL-5-NITROPYRIMIDINE TETRACHLORIDE DIHYDROCHLORIDE HEXAHYDRATE FOR THE TREATMENT OF HERPETIC INFECTION AND A TOPICAL PHARMACEUTICAL COMPOSITION LIMITED LIABILITY COMPANY "NEARMEDIC PLUS" (RU) 2015-11-05 WO disclosed